See you next year! September 15 -18, 2025
Hynes Convention CenterBoston, USA Michael RobertsCo-Founder & CEO at Adaptin Bio, Inc.Speaker
Profile
Dr. Roberts has 25+ years of pharmaceutical research, development, corporate development, and executive experience. He is co-founder and CEO of Adaptin Bio. Prior to Adaptin Bio he was co-founder and Acting CEO of Corino Therapeutics. He is a pharmaceutical and biotech consultant and owner of MAC B Consulting. Prior to Corino, Dr. Roberts was VP, Business Development and Corporate Officer of publicly traded Chelsea Therapeutics, Inc. where he led the sale of Chelsea Therapeutics to H. Lundbeck A/S in 2014 for $658M. Dr. Roberts has completed pharmaceutical transactions valued at over $1B.
Agenda Sessions
Modified Adoptive Cell Therapy for the Targeted Delivery of T Cell Engagers for Treatment of Glioblastoma (GBM)
, 12:15pmView Session